The two DNA lntercalators, actlnomycln D and 2-methyi-9-hydroxy-elhptlclne, and the DNA minor groove ligant DAPI inhibited the growth of the haloarchaeon Halobactenum sp GRB and bind to its plasmid pGRB-1 In contrast to specific DNA topoisomerase |I mhibltors, they produced neither double-stranded breaks nor relaxation of plasmldic DNA The two DNA intercalators inhibited positive supercolhng induced by novoblocm, suggesting that positive supercolhng in haloarchaea is due to transcription, as m the domain Bacteria Plasmlds from haloarchaea could thus be used to prescreen for DNA mtercalators and to discriminate between different drug families via their mode of action
Introduction
DNA topolsomerases have attracted much attention as targets of several drug famlhes bacterial DNA gyrases are inhibited by coumarlns and qumolones, whereas eucaryal DNA topolsomerases I and II are inhibited by several antmeoplaslc drugs currently used m chemotherapy [1] Coumarms lnterfer with ATP binding, whereas qulnolones and most antltumoral drugs stablhze the covalent binding of these enzymes to DNA Among the latter, some drugs bind only to the DNA-enzyme complex, whereas others can bind * Corresponding author Fax +33 (1) 6941-7808, e-mail forterre@igmors u-psud fr to the DNA via intercalation or binding to the helix mmor groove All these lnhlbltors are powerful tools to study the role of DNA tOpOlSOmerases m VlVO We previously reported that halophlhc archaea (haloarchaea) are sensitive to both lnhlbltors of bacterial DNA gyrases (fluoroqumolones and coumarlns) and lnhlbltors of eucaryal DNA topolsomerases II (eptpodophyllotoxms) [2] [3] [4] This result correlates with the umque phylogenetlc posmon of Archaea, as intermediate between Bacteria and Eucarya [5] Some of these lnh~bltors produced structural and topological changes into plasmlds of haloarchaea, similar to those observed m Bacteria or Eucarya novoblocm induced positive supercolhng [6] , whereas fluoroqulnolones and eplpodophyllotoxmes induced DNA cleavage [2, 7] We have thus sug-gested that plasmlds from haloarchaea could be used to prescreen in vivo for drugs active against DNA topolsomerases [7] In our previous work, we have only tested DNA topoisomerase lnhibltors that do not bind to DNA Here, we report the effect of three DNA binding drugs on the haloarchaeon Halobactenum GRB and its multlcopy plasmld pGRB-1 with the aim to compare their effects with those of specific DNA topoisomerase lnhlbitors We have tested two DNA lntercalators, actmomycln D and 2-methyl-9-hydroxy-elhptlcme (C1 Me He), and DAPI, a DNA minor groove hgant All these drugs inhibit the growth of Halobactertum GR-B and modify the electrophoretic mobility of the plasmId PGRB-1 In addition, the two DNA lntercalators tested inhibit positive supercoihng induced by novobIocin This indicates that different families of drugs can be discriminated by their effects on haloarchaeal plasmlds
Materials and Methods

Enzymes and chemwals
Protelnase K, rlbonuclease A, novoblocin and actlnomycln D were obtained from Sigma Chemical Co (St Louis, MO, USA) 2-methyl-9-hydroxy-elhptlclne (C1 Me He), and 4',6-dlamlno-2-phenyhndol (DAPI) were gifts from Dr J B Le Pecq (InstltUt Gustave Roussy, Villejulf, France) and Dr C Zimmer (Iena, FRG), respectively All drugs were dissolved in dimethyl-sulfoxade with the exception of novoblocin which was dissolved in water and the topoprofile of the small plasm~d pGRB-1 were msensltwe to dlmethyl-sulfoxlde at the concentranon used
ID50 determmatton and plasmtd analyses
The cells were grown as described [4] and the drugs were added at an optical denslty of 0 3 at 600 nm For ID 50 determination, the A 600 was measured at different times and drug concentrations, the half-inhibitory dose was estabhshed with untreated cells as 100% control For plasmid analyses, the ceils were collected by centrlfugatlon 24 h after drug addlnon, the supernatant was discarded to ehmmate the drug and washed with basalt salt buffer containing 4 M NaC1, 0 2 M MgSO4, 0 01 M trisodlum citrate pH 7 2 The cells were then lyzed by rapid suspension m Tns HC1 10 mM pH 8, EDTA 1 mM Such a direct and quick procedure avoids artefactual DNA cleavage In addition, since the halophlhc enzymes are mactwe m the absence of salt, the topology and structure of the plasm~d were similar both m wtro and m vwo After 5 mln, the lysate was adjusted to 1% SDS w~th TRIS-EDTA buffer and centrifuged to remove cells debris Sample of the supernatant were treated with RNAse for 30 mm at 37°C followed by protelnase K treatment for 1 h at 37°C Total DNA was run on agarose gel as described [4] The different plasmld forms were wsuahzed after transfer onto a nitrocellulose filter by the Southern method The cold pGRB-1 probes were prepared accordlng to the non-radioactive DNA labehng and detecnon standard procedure of Boerhlnger Mannhelm, where the DNA is labeled with dlgoxlgenm-ll-dUTP
Results and Discussmn
The three DNA binding drugs tested inhibited the growth of Halobactenum GRB with ID 50 of 2, 4 and 12/zg/ml for actmomycm D, C1 Me He, and DAPI, respectwely (Fig 1, upper panels) Residual growth was observed m the presence of the elhptlcme The pGRB-1 plasmld was still present m drug treated cells, whereas the high molecular weight plasmlds disappeared at high 163 drug concentrations (Fig 1, lower panels) , a result previously observed with novoblocm [3] However, the electrophoretlc moblhty of the plasmid pGRB-1 isolated from cells treated with high drug concentrations was severely retarded Butanol treatment of the samples ehmmated th~s migration shift, indicating the presence of drug bond onto the plasmlds in untreated samples (Fig 1) This result indicated that DNA binding drugs can brad onto the DNA of haloarchaea in vwo desplte the high salt concentration in the cytoplasm of these extremophlles (3-4 M KCL, 1 M MgC12), and remained attached to the plasmld during cell lysls and gel electrophoresls In the three cases analyzed, the lowest drug concentranon altering the mlgranon pattern were s~mflar to the ID 50, indicating that the primary target of these drugs was probably the DNA itself We have prewously shown that two DNA lntercalators of the antracychn family, adnamycm and daunorubicm, lnhlblted the growth of Halobactenum halobtum with ID50 of 10 and 7/zg/ml, respectively [4] , we have found that these drugs also inhibit the growth of Halobactertum GRB at similar concentranons and attached to the pGRB-1 plasmld (not shown) These results indicate that, m addmon to specific DNA topo~so-merase lnhlbltors, DNA binding drugs can be readily detected m the haloarchaeal system DNA topolsomerase II mhlbltors which stablhzes the cleavable complex but do not brad on the DNA, such as eplpodophyllotoxlns and fluoroqumolones, introduce double-stranded breaks and relax the remaining topologically closed plasmlds [2, 7] CIMeHe, DAPI and to a lesser extent actlnomycln D, induced single-stranded breaks m PGRB-1, but none of the DNA blndmg drugs tested here induced double-stranded breaks or DNA relaxanon (Fig 1) This difference correlates w~th observations made m eucaryotes since ~t has been reported that several DNA mtercalators and minor groove binding drugs mh~blt DNA topo~somerase actwlnes but without inducing DNA cleavage m mamahan systems [9] [10] [11] [12] Thus, our results further extend the similarities between eucaryal and archaeal responses to anntumoral drugs They show that the two classes of drugs, DNA topolsomerase mhlbltors and DNA 164 binding agents, can be readily discriminated in the haloarchaeal system, the former did not change the plasmid electrophoretic mobility but induce double-stranded breaks whereas the latter change the electrophoretic mobility but did not induce double-stranded breaks
We have previously shown that the pGRB-1 plasmids are positively supercolled in novobloclntreated cells [6] During the present study with DNA binding agents, we have noted that actInomycin D and CIMeHe inhibited this phenomenon (Fig 2) Plasmids isolated from cells treated with 2 /zg/ml of novoblocln migrated in agarose gel as a ladder of tOpOlsomers whose electrophoretic mobility was increased by ethIdium bromide, demonstrating positive supercoihng (lanes 3) Comparison of lanes 3, 5 and 6, in the three panels shows that plasmlds isolated from cells co-treated with novoblocin and CI Me He (10 and 20 /zg/ml) were less positively supercoiled The effect of actlnomycln D was more drastic the electrophoretlc mobility of plasmids isolated from cells co-treated with novoblocIn and 10 or 50/xg/ml of actinomycin D was decreased by ethldlum bromide (compare lanes 11 and 12 m the three panels), indicating negative supercolllng Furthermore, they exhibited the same level of negative superhehoty as the plasmld control (lane 2) Concentrations of actinomycln D above 10/zg/ml thus completely reverse the action of novoblocm We observed the same effect with another DNA binding drug, adriamycln (not shown) In contrast, DAPI has no effect up to 15 /zg/ml (compare lanes 3 with 8 and 9 ), we could not tested h~gher concentrations since we failed to recover enough plasmlds from cells co-treated with novoblocln and high DAPI concentrations We prevmusly suggested that novoblocln-lnduced positwe supercolhng (NIPS) m haloarchaea was produced by a reverse gyrase actwlty unmasked m the absence of DNA topolsomerase II actwlty [6] This hypothesis appears now unlikely since reverse gyrase is apparently absent in mesophdlc archaea [13] A better explanation is that NIPS is due to transcriptional supercofllng, as in Bacteria, in agreement with the twin-domains model of Llu and Wang [14] In Bacterta, lnhlbltmn of DNA gyrase by novoblocm induces posltwe supercolllng because this enzyme is the only DNA tOpOlsomerase which can relax the wave of positive superturns produced in front of moving RNA polymerases The inhibition of NIPS by actlnomycln D in haloarchaea strongly suggests that archaeal NIPS is also Induced by transcriptional supercolhng, since this drug ~s a strong inhibitor of the RNA polymerase from haloar-165 chaea [15] Adnmaycln is also known to inhibit RNA synthesis in vitro [16] The mechanism of NIPS has been demonstrated in Bacteria using rlfamplcln, a specific inhibitor of bacterial RNA polymerase [17] Unfortunately, rlfamplcln cannot be used to check this model in haloarchaea, since their RNA polymerase is not sensitive to this drug [15] The growth of H sahnartum cells is inhibited by rlfamplcln concentrations above 25 /xg/ml, but this mhIbitmn is correlated with immediate cell lysls, suggesting that rlfampicln has a detergent effect for the genus Halobactertum (unpublished observation) We have previously argued against the transcriptional hypothesis for NIPS of pGRB-1 because we detected a single pGRB-1 transcript in Halobactertum GRB [6] However, Tsao and co-workers have shown later that transcription from a single promoter in wtro can induce positive supercolhng [18] These authors suggested that the fusion of posltwe and negatwe supercoils within the same DNA circle must be slow compared to the rate of topolsomerase-catalyzed relaxation of negative supercoils The transcription of the single pGRB-1 ORF could thus be sufficient to produce a net accumulation of posltwe superturns in the absence of type II DNA topolsomerase actwlty Our results therefore suggest that the pGRB-1 plasmid could be also used to Identify transcription lnhlbltors via their effect on NIPS In th~s work, the two intercalators tested inhibit NIPS, whereas the minor groove binder Table 1 Effect of DNA topolsomerase mhlbltors on the topology of the archaeal plasmld pGRB-1 from Halobactertum sp GRB DAPI has no effect at the concentrations used This could reflect a general and specific inhibitory effect of DNA lntercalators on transcription m haloarchaea However, more work ~s required to generahze these observations In particular, It has been shown that DAPI mhlblts in vitro transcription by E colt RNA polymerase [19] Since DAPI has the highest ID50 among the three drugs that we have tested, ~t might be possible that other minor groove bmdmg drugs with highest DNA affinity could also mhlblt transcription and NIPS in haloarchaea Table 1 summarizes the different antibiotics actwe against Halobactenum sp GRB and whose action can be momtored wa structural or topological changes in pGRB-1 In contrast to Bacteria or Eukarya, the haloarchaea appeared to be permeable and sensltwe to all types of DNA binding drugs and DNA topolsomerase mhlbltors tested Accordingly, the haloarchaeal system described here should be especmUy interesting to identify such componds m complex medm containing nuclease activities which could mterfer w~th in vitro DNA binding or DNA topolsomerase assays
